These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11353892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies.
    Lacroix A, N'Diaye N, Mircescu H, Tremblay J, Hamet P.
    Braz J Med Biol Res; 2000 Oct; 33(10):1201-9. PubMed ID: 11004721
    [Abstract] [Full Text] [Related]

  • 3. Abnormal expression and function of hormone receptors in adrenal Cushing's syndrome.
    Lacroix A, N'Diaye N, Mircescu H, Hamet P, Tremblay J.
    Endocr Res; 1998 Oct; 24(3-4):835-43. PubMed ID: 9888584
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?
    Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, Lacroix A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3531-6. PubMed ID: 11061496
    [Abstract] [Full Text] [Related]

  • 8. Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
    Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Barrande G, Bertherat J, Vaudry H, Lefebvre H.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4578-86. PubMed ID: 16954157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
    Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H.
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
    [Abstract] [Full Text] [Related]

  • 13. Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors.
    Christopoulos S, Bourdeau I, Lacroix A.
    Horm Res; 2005 Mar; 64(3):119-31. PubMed ID: 16215323
    [Abstract] [Full Text] [Related]

  • 14. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study.
    Mannelli M, Ferruzzi P, Luciani P, Crescioli C, Buci L, Corona G, Serio M, Peri A.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4616-22. PubMed ID: 14557431
    [Abstract] [Full Text] [Related]

  • 15. Two cases of Cushing's syndrome due to primary bilateral macronodular adrenal hyperplasia secondary to aberrant adrenal expression of hormone receptors.
    Juliá-Sanchis MLL, Navarro-Téllez MDP, Falcones-Gracia KV, Ricart-Álvarez E, González-Bueno MV, Molina-Gasset R.
    Clin Biochem; 2018 Sep; 59():86-89. PubMed ID: 29936051
    [Abstract] [Full Text] [Related]

  • 16. Aberrant expression of hormone receptors in adrenal Cushing's syndrome.
    Christopoulos S, Bourdeau I, Lacroix A.
    Pituitary; 2004 Sep; 7(4):225-35. PubMed ID: 16010457
    [Abstract] [Full Text] [Related]

  • 17. Cushing's syndrome secondary to ACTH-independent macronodular adrenal hyperplasia.
    Costa MH, Lacroix A.
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1226-37. PubMed ID: 18209860
    [Abstract] [Full Text] [Related]

  • 18. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent cushing's syndrome.
    N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2616-22. PubMed ID: 10443649
    [Abstract] [Full Text] [Related]

  • 19. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.
    Chasseloup F, Bourdeau I, Tabarin A, Regazzo D, Dumontet C, Ladurelle N, Tosca L, Amazit L, Proust A, Scharfmann R, Mignot T, Fiore F, Tsagarakis S, Vassiliadi D, Maiter D, Young J, Lecoq AL, Deméocq V, Salenave S, Lefebvre H, Cloix L, Emy P, Dessailloud R, Vezzosi D, Scaroni C, Barbot M, de Herder W, Pattou F, Tétreault M, Corbeil G, Dupeux M, Lambert B, Tachdjian G, Guiochon-Mantel A, Beau I, Chanson P, Viengchareun S, Lacroix A, Bouligand J, Kamenický P.
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):813-824. PubMed ID: 34655521
    [Abstract] [Full Text] [Related]

  • 20. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, Ichikawa T, Sasano H, Saito Y.
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.